Product Information
FONDAPARINUX 10 MG/0.8 ML SYR is a generic product labeled by Mylan Institutional LLC, priced at $46.0327 per ML under NDC 67457058508. Its NADAC has been published 214 times since Jul 20, 2022.
FDA first approved this application on Dec 7, 2001. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/.8mL
Manufacturer
Mylan Institutional LLCNDC
67457058508
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA021345FDA Approved
12/7/2001
TE Code
AP
On Market Since
1/5/2015
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has been published 214 times since Jul 20, 2022, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.0327 per ML |
|---|---|
| All-time high | $53.5408 (May 15, 2024) |
| All-time low | $29.5253 (May 21, 2025) |
| 52-week high | $46.2815 |
| 52-week low | $31.8179 |
| Median price | $44.3180 |
| Average price | $43.1701 |
| Largest weekly change | -26.6% (May 22, 2024) |
| Weeks tracked | 214 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FONDAPARINUX 10 MG/0.8 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 10 MG/0.8 ML SYR, manufactured by Mylan Institutional LLC, is $46.0327 per ML (NDC 67457058508), effective Aug 19, 2026.
How has the price of FONDAPARINUX 10 MG/0.8 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has declined 8.0%. It has been tracked across 214 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 10 MG/0.8 ML SYR?
Since Jul 20, 2022, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has ranged from a low of $29.5253 (May 21, 2025) to a high of $53.5408 (May 15, 2024), with a median of $44.3180 per ML.
Are there cheaper alternatives to FONDAPARINUX 10 MG/0.8 ML SYR?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 10 MG/0.8 ML SYR, is $18.3687 per ML — about 60% below FONDAPARINUX 10 MG/0.8 ML SYR.
Who manufactures FONDAPARINUX 10 MG/0.8 ML SYR?
FONDAPARINUX 10 MG/0.8 ML SYR (NDC 67457058508) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.